Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear RNA-activating complex polypeptide 4 (SNAPC4) is the largest subunit of the small nuclear RNA-activating protein complex (SNAPc), a multi-protein transcription factor essential for the transcription of small nuclear RNA (snRNA) genes by RNA polymerase II and RNA polymerase III. It contains a Myb-domain that mediates DNA binding to the promoter-proximal sequence element (PSE), facilitating the recruitment of the transcription machinery. SNAPC4, together with other SNAPc subunits, is required for proper assembly and function of the spliceosomal snRNPs, which are critical for pre-mRNA splicing. In model organisms, mutations in SNAPC4 can disrupt snRNA expression and lead to developmental abnormalities, such as loss of biliary epithelial cells in zebrafish. Human genetic studies link SNAPC4 to neurodevelopmental and cardiac disorders. It is not currently considered a direct therapeutic target, receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear RNA-activating complex polypeptide 4 (SNAPC4).